Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEDARCURE SLIT-tablet special drug use surveillance
jRCT1080224132Recruiting
- Sponsor
- Torii Pharmaceutical
- Start
- Nov 2018
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of japanese cedar pollen in Japanese cedar pollinosis and seasonal allergic rhinitis (SAR), sponsored by Torii Pharmaceutical. Started Nov 2018; status: recruiting.
02
Drugs
japanese cedar pollen
03
Conditions
Japanese cedar pollinosisseasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCT1080224132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224132.